Viewing Study NCT04398433


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2025-12-30 @ 7:07 PM
Study NCT ID: NCT04398433
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2020-05-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)
Sponsor: Inovio Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-06-15
Start Date Type: ACTUAL
Primary Completion Date: 2022-12-15
Primary Completion Date Type: ACTUAL
Completion Date: 2022-12-15
Completion Date Type: ACTUAL
First Submit Date: 2020-05-14
First Submit QC Date: None
Study First Post Date: 2020-05-21
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2023-12-12
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-09-06
Last Update Post Date: 2024-09-19
Last Update Post Date Type: ACTUAL